73147 mTOR Inhibitors for Healthspan Extension: A Meta-analysis of Randomized Trials
Journal of the American Academy of Dermatology · 2026-07 · 95 (1) · AB7
DOI: 10.1016/j.jaad.2026.04.045 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Journal of the American Academy of Dermatology, 2026-07. Verfasst von Lorena Oliveira Fonseca und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Fonseca, L. O., Kuceki, G., Li, S. W. R., Mendoza-Millán, D. L., Junior, E. B. D. D. N., Garza-Dueñas, G. G., & Wambier, C. G. (2026). 73147 mTOR Inhibitors for Healthspan Extension: A Meta-analysis of Randomized Trials. Journal of the American Academy of Dermatology, 95(1), AB7. https://doi.org/10.1016/j.jaad.2026.04.045
Vancouver
Fonseca LO, Kuceki G, Li SWR, Mendoza-Millán DL, Junior EBDDN, Garza-Dueñas GG, et al. 73147 mTOR Inhibitors for Healthspan Extension: A Meta-analysis of Randomized Trials. Journal of the American Academy of Dermatology. 2026;95(1):AB7. doi:10.1016/j.jaad.2026.04.045
BibTeX
@article{Fonseca2026,
author = {Fonseca, Lorena Oliveira and Kuceki, Guilherme and Li, Sze Wai Rosa and Mendoza-Millán, Daniela L. and Junior, Evardo Barros de Deus Nunes and Garza-Dueñas, Georgina G. and Wambier, Carlos Gustavo},
title = {73147 mTOR Inhibitors for Healthspan Extension: A Meta-analysis of Randomized Trials},
journal = {Journal of the American Academy of Dermatology},
year = {2026},
volume = {95},
number = {1},
pages = {AB7},
doi = {10.1016/j.jaad.2026.04.045}
}
EUVIMED